Metabolic Syndrome Clinical Trial
Official title:
High Intensity Training Based on Small-sided Soccer Games for Health: Effects on Cardiometabolic Health, Motor Performance and Adherence to 24-hour Movement Guidelines in Adolescents With Overweight and Metabolic Dysfunction
Verified date | April 2024 |
Source | Universidade do Porto |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Pediatric obesity is considered one of the most important public health problems worldwide due to its high prevalence and associated comorbidities. Physical exercise has been shown to have an important role in the treatment of obesity and associated cardiometabolic dysfunction. Small-sided soccer games (SSSG) have been explored as a promising way of increasing physical exercise due to its benefits on cardiometabolic health and high degree of enjoyment, which favors long-term adherence. The objective of this research is to determine the effects of a 16-week high-intensity SSSG-based exercise intervention on cardiometabolic risk factors, physical fitness, adherence to 24-hour movement patterns, enjoyment and adherence to the intervention in adolescents with metabolic dysfunction and compare them to the effects of a traditional soccer intervention. The investigators hypothesize that high-intensity SSSG are more effective in improving the obesity-related cardiometabolic risk profile in adolescents with cardiometabolic dysfunction compared to traditional soccer training. A parallel 3-arm randomized controlled trial will be conducted in adolescents with overweight and metabolic dysfunction between 11 and 15 years of age. The inclusion criteria are: (i) age between 11-15 years at the time of intervention start; (ii) overweight or obesity (BMI> 85th percentile); (iii) Abdominal obesity ≥90th percentile as assessed by waist circumference or a waist-to-height ratio ≥ 0.5; (iv) willing to participate in the study regardless of possible group allocation; (v) informed consent given by participant and legal representatives. Exclusion criteria: (i) health condition not compatible with participation in physical exercise; (ii) history of recent musculoskeletal injury hindering exercise participation; (iii) concurrent participation in a structured weight loss or exercise program. Those eligible to participate in the study will be randomly assigned to one of three groups: i) SSSG group, ii) traditional soccer play group (TSG), or, iii) non-exercise intervention control group (CG). Participants in both exercise intervention groups will undergo a 16-week intervention. The SSSG group will participate in a high-intensity small-sided soccer games training, while the TSG will undergo a technical and tactical skills training program and traditional soccer training. The CG participants will continue with regular school physical education classes without any additional intervention. Before and after the intervention, all participants will be assessed for cardiometabolic and hepatic biochemical markers, physical fitness, anthropometry and body composition, blood pressure, objective daily physical activity and sleep quality, and perceived enjoyment of participation in SSSG and TSG. The primary outcomes of the study will be waist circumference and cardiorespiratory fitness. The study protocol was approved by the Ethics Committee of the Faculty of Sport of the University of Porto and by the Scientific Ethics Committee of the Adventist University of Chile.
Status | Completed |
Enrollment | 51 |
Est. completion date | September 1, 2023 |
Est. primary completion date | April 10, 2023 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 11 Years to 15 Years |
Eligibility | Inclusion Criteria: - Age between 11-15 years at the time of intervention start - Overweight or obesity (BMI> 85th percentile) - Abdominal obesity =90th percentile as assessed by waist circumference or a waist-to- height ratio = 0.5 - Willing to participate in the study regardless of possible group allocation - Informed consent given by participant and legal representatives Exclusion Criteria: - Health condition not compatible with participation in physical exercise - History of recent musculoskeletal injury hindering exercise participation - Concurrent participation in a structured weight loss or exercise program |
Country | Name | City | State |
---|---|---|---|
Portugal | Faculty of Sport of the University of Porto | Porto |
Lead Sponsor | Collaborator |
---|---|
Universidade do Porto |
Portugal,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Waist circumference | Anthropometric measurement of abdominal obesity; cm | 16 weeks | |
Primary | Cardiorespiratory fitness | 1-mile walk/run test; minutes to run 1 mile | 16 weeks | |
Secondary | Variation in fasting blood glucose concentration (mg/dL) | Variation in fasting blood glucose concentration after 16 weeks of intervention.
Blood samples will be obtained from each subject early in the morning by venipuncture from the antecubital vein, following a 10-h overnight fast. |
16 weeks | |
Secondary | Variation in serum insulin concentration (mU/L) | Variation in serum insulin concentration after 16 weeks of intervention.
Blood samples will be obtained from each subject early in the morning by venipuncture from the antecubital vein, following a 10-h overnight fast. |
16 weeks | |
Secondary | Variation in HOMA-IR | Variation in HOMA-IR after 16 weeks of intervention.
Blood samples will be obtained from each subject early in the morning by venipuncture from the antecubital vein, following a 10-h overnight fast. |
16 weeks | |
Secondary | Variation in glycosylated hemoglobin concentration (mg/dL) | Variation in Glycosylated hemoglobin concentration after 16 weeks of intervention.
Blood samples will be obtained from each subject early in the morning by venipuncture from the antecubital vein, following a 10-h overnight fast. |
16 weeks | |
Secondary | Variation in high-density lipoprotein cholesterol concentration (mg/dL) | Variation in High-density lipoprotein cholesterol concentration after 16 weeks of intervention.
Blood samples will be obtained from each subject early in the morning by venipuncture from the antecubital vein, following a 10-h overnight fast. |
16 weeks | |
Secondary | Variation in low-density lipoprotein cholesterol concentration (mg/dL) | Variation in low-density lipoprotein cholesterol concentration after 16 weeks of intervention.
Blood samples will be obtained from each subject early in the morning by venipuncture from the antecubital vein, following a 10-h overnight fast. |
16 weeks | |
Secondary | Variation in total cholesterol concentration (mg/dL) | Variation in total cholesterol concentration after 16 weeks of intervention.
Blood samples will be obtained from each subject early in the morning by venipuncture from the antecubital vein, following a 10-h overnight fast. |
16 weeks | |
Secondary | Variation in blood triglycerides concentration (mg/dL) | Variation in blood triglycerides concentration after 16 weeks of intervention.
Blood samples will be obtained from each subject early in the morning by venipuncture from the antecubital vein, following a 10-h overnight fast. |
16 weeks | |
Secondary | Variation in blood Alanine aminotransferase concentration (U/L) | Variation in blood Alanine aminotransferase concentration after 16 weeks of intervention.
Blood samples will be obtained from each subject early in the morning by venipuncture from the antecubital vein, following a 10-h overnight fast. |
16 weeks | |
Secondary | Variation in blood Aspartate aminotransferase concentration (U/L) | Variation in blood Aspartate aminotransferase concentration after 16 weeks of intervention.
Blood samples will be obtained from each subject early in the morning by venipuncture from the antecubital vein, following a 10-h overnight fast. |
16 weeks | |
Secondary | Variation in blood Gamma glutamyl transferase concentration (U/L) | Variation in blood Gamma glutamyl transferase concentration after 16 weeks of intervention.
Blood samples will be obtained from each subject early in the morning by venipuncture from the antecubital vein, following a 10-h overnight fast. |
16 weeks | |
Secondary | 6-minute walk test | Distance covered walking in 6 minutes. | 16 weeks | |
Secondary | Hand grip strength | Hand grip strength test measured with a digital hand dynamometer | 16 weeks | |
Secondary | Lower limb strength | Assessed by Horizontal jump test. | 16 weeks | |
Secondary | Body composition | Assessed by the electrical bioimpedance method | 16 weeks | |
Secondary | Body mass index | Weight and height will be combined to report BMI in kg/m^2 | 16 weeks | |
Secondary | Neck circumference | Assessed by anthropometric techniques | 16 weeks | |
Secondary | Blood Pressure (mmHg) | Systolic and diastolic blood pressure measured with digital sphygmomanometer | 16 weeks | |
Secondary | Physical activity | Physical activity will be assessed objectively with a triaxial accelerometer used 24h/d during 7 consecutive days. | 16 weeks | |
Secondary | Sleep quality | Sleep quality will be assessed objectively with a triaxial accelerometer used 24h/d during 7 consecutive days. | 16 weeks | |
Secondary | Perceived enjoyment of physical activity | Assessed by the Physical Activity Enjoyment Scale questionnaire (PACES). Raw scores are transformed into a scale from 16 to 80. Higher scores correspond to higher perceived enjoyment. | 16 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04635202 -
Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome
|
N/A | |
Completed |
NCT05343858 -
Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome
|
N/A | |
Completed |
NCT04053686 -
An Intervention to Reduce Prolonged Sitting in Police Staff
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Recruiting |
NCT05040958 -
Carotid Atherosclerotic Plaque Load and Neck Circumference
|
||
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Active, not recruiting |
NCT02500147 -
Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
|
Phase 4 | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Completed |
NCT03289897 -
Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan
|
N/A | |
Recruiting |
NCT05956886 -
Sleep Chatbot Intervention for Emerging Black/African American Adults
|
N/A | |
Completed |
NCT06057896 -
Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
|
||
Active, not recruiting |
NCT03613740 -
Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
|
Phase 2 | |
Completed |
NCT04498455 -
Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency
|
Phase 4 | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
Completed |
NCT03697382 -
Effect of Daily Steps on Fat Metabolism
|
N/A | |
Completed |
NCT03241121 -
Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome
|
N/A | |
Completed |
NCT04509206 -
Virtual Teaching Kitchen
|
N/A | |
Completed |
NCT05124847 -
TREating Pediatric Obesity
|
N/A |